At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Michael Untch (HELIOS Klinikum Berlin-Buch, Berlin, Germany) and Prof. Dr. med. Peter Fasching (Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany) discuss the functions of the BRCA1 and BRCA2 proteins in response to DNA damage in BRCA-related breast cancer. The development of molecular profiling in BRCA-related breast cancer has allowed an increasingly accurate assessment of tumour biology and should allow us to utilise this mutation in the treatment of the cancer.
This programme is supported by BioMarin Pharmaceutical.
